We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

190 hedge funds and large institutions have $454M invested in Heron Therapeutics in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 15

72% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 39

37% more capital invested

Capital invested by funds: $331M → $454M (+$123M)

18% more funds holding

Funds holding: 161 → 190 (+29)

6.65% more ownership

Funds ownership: 79.39% → 86.04% (+6.7%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

32% less call options, than puts

Call options by funds: $532K | Put options by funds: $781K

Holders
190
Holders Change
+29
Holders Change %
+18.01%
% of All Funds
2.74%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
45
Increased
67
Reduced
39
Closed
15
Calls
$532K
Puts
$781K
Net Calls
-$249K
Net Calls Change
-$4.55M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.4M
2
State Street
State Street
Massachusetts
+$8.73M
3
Marshall Wace
Marshall Wace
United Kingdom
+$3.89M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.59M
5
BlackRock
BlackRock
New York
+$3.19M

Top Sellers

1
O
OrbiMed
New York
-$11.1M
2
Millennium Management
Millennium Management
New York
-$5.32M
3
CC
Clearline Capital
New York
-$3.94M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.27M
5
MAM
Monaco Asset Management
Monaco
-$922K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
76
Group One Trading
Illinois
$190K +$167K +54,252 New
XT
77
XTX Topco
Cayman Islands
$190K -$475K -154,582 -74%
JP Morgan Chase
78
JP Morgan Chase
New York
$183K +$29.9K +9,740 +23%
IWC
79
Integrated Wealth Concepts
Massachusetts
$178K +$6.14K +2,000 +4%
Citigroup
80
Citigroup
New York
$177K +$101K +33,017 +189%
Federated Hermes
81
Federated Hermes
Pennsylvania
$176K +$1.75K +570 +1%
PA
82
Profund Advisors
Maryland
$168K +$148K +48,073 New
GC
83
Grimes & Company
Massachusetts
$168K +$2.74K +893 +2%
BCM
84
Bayesian Capital Management
New York
$167K +$146K +47,600 New
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$160K +$19.4K +6,328 +16%
Lido Advisors
86
Lido Advisors
California
$159K – – –
KOCAA
87
Knights of Columbus Asset Advisors
Connecticut
$146K – – –
Invesco
88
Invesco
Georgia
$145K -$17.9K -5,823 -12%
VF
89
Virtu Financial
New York
$141K +$123K +40,165 New
VOYA Investment Management
90
VOYA Investment Management
Georgia
$138K +$19.6K +6,378 +19%
T. Rowe Price Associates
91
T. Rowe Price Associates
Maryland
$132K +$23.3K +7,573 +25%
Wealth Enhancement Advisory Services
92
Wealth Enhancement Advisory Services
Minnesota
$131K +$4.2K +1,366 +4%
Acadian Asset Management
93
Acadian Asset Management
Massachusetts
$127K +$112K +36,462 New
BBA
94
Baader Bank Aktiengesellschaft
Germany
$126K +$111K +36,128 New
RJFSA
95
Raymond James Financial Services Advisors
Florida
$118K -$71.1K -23,140 -41%
SOW
96
State of Wyoming
Wyoming
$115K -$71.7K -23,347 -42%
WA
97
Wealth Alliance
New York
$112K +$36.9K +12,000 +60%
SF
98
Synovus Financial
Georgia
$111K +$97.8K +31,847 New
HSBC Holdings
99
HSBC Holdings
United Kingdom
$111K -$599 -195 -0.6%
Deutsche Bank
100
Deutsche Bank
Germany
$110K -$38.6K -12,549 -29%
2 3
4
5 6

HRTX Hedge Fund Activity: Q2 2024 in Review

190 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2024, worth a combined $454M — up 37% from $331M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new HRTX positions and 15 closed out — a net gain of 30 holders — while 67 added to existing stakes and 39 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $14.4M. The largest seller was OrbiMed, cutting an estimated $11.1M.

  • 190 institutional investors held Heron Therapeutics (HRTX) as of Q2 2024, up from 161 in Q1 2024.
  • Funds reported $454M of Heron Therapeutics stock for Q2 2024, up 37% quarter-over-quarter.
  • 45 funds opened new Heron Therapeutics positions in Q2 2024 and 15 closed out, a net change of +30 holders.
  • The largest Heron Therapeutics buyer in Q2 2024 was Adage Capital Partners, an estimated $14.4M added.
  • The largest Heron Therapeutics seller in Q2 2024 was OrbiMed, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2024.